SCHEMBL20472995

SCHEMBL20472995

CC(C)(C)C(N)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19194817 1.00
SCHEMBL10002515 1.00
Hydrochloric Acid SCHEMBL11972147 0.97
Hydrochloric Acid SCHEMBL1515646 0.97
SCHEMBL276866 0.76
SCHEMBL179325 0.76
SCHEMBL179389 0.76
SCHEMBL23551204 0.73
Hydrochloric Acid SCHEMBL4649837 0.73
Bromide SCHEMBL9978607 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3385252-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2018-10-10 EP claimed
CN-109689654-A 7-substituted 1-pyridyl-naphthyridine-3-carboxamides and their use 拜耳医药股份有限公司 2019-04-26 CN disclosed
EP-3385252-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2018-10-10 EP disclosed
EP-3363788-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2018-08-22 EP disclosed